Medindia
Medindia LOGIN REGISTER
Advertisement

Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST

Wednesday, August 7, 2019 General News
Advertisement
-- FDA grants priority review and sets PDUFA date for February 14, 2020 --

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close